We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

122 hedge funds and large institutions have $331M invested in Dynavax Technologies in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $55.3M | Put options by funds: $27.6M

41% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 29

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

1% more funds holding

Funds holding: 121122 (+1)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

30% less capital invested

Capital invested by funds: $470M → $331M (-$139M)

Holders
122
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
25
Increased
41
Reduced
29
Closed
24
Calls
$55.3M
Puts
$27.6M
Net Calls
+$27.7M
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$861K +$8.62K +600 +0.7%
Allianz Asset Management
52
Allianz Asset Management
Germany
$855K -$518K -36,025 -31%
BBA
53
Baker Bros. Advisors
New York
$787K
American Century Companies
54
American Century Companies
Missouri
$712K -$72.1K -5,015 -7%
TA
55
Teachers Advisors
New York
$651K
Barclays
56
Barclays
United Kingdom
$601K +$824K +57,326 New
Swiss National Bank
57
Swiss National Bank
Switzerland
$594K -$31.6K -2,200 -4%
CS
58
Credit Suisse
Switzerland
$579K +$311K +21,623 +64%
VKH
59
Virtu KCG Holdings
New York
$530K +$727K +50,554 New
AllianceBernstein
60
AllianceBernstein
Tennessee
$479K
MFM
61
MHR Fund Management
New York
$467K
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$425K +$56.1K +3,900 +11%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$420K +$10.9K +760 +2%
T. Rowe Price Associates
64
T. Rowe Price Associates
Maryland
$382K +$152K +10,600 +41%
HCM
65
Highbridge Capital Management
New York
$343K +$470K +32,726 New
Bank of America
66
Bank of America
North Carolina
$338K -$19.1M -1,325,863 -98%
EA
67
Emerald Acquisition
Washington
$336K -$4.64K -323 -1%
NIT
68
NumerixS Investment Technologies
British Columbia, Canada
$297K +$407K +28,300 New
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$294K
FO
70
FT Options
Illinois
$284K +$388K +27,030 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$281K -$8.32K -579 -2%
CCP
72
Clough Capital Partners
Massachusetts
$278K -$3.12M -217,384 -89%
NFA
73
Nationwide Fund Advisors
Ohio
$261K
Mariner
74
Mariner
Kansas
$259K +$354K +24,624 New
FPC
75
Falcon Point Capital
California
$238K +$57.8K +4,023 +18%

DVAX Hedge Fund Activity: Q3 2016 in Review

122 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2016, worth a combined $331M — down 30% from $470M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DVAX positions and 24 closed out — a net gain of 1 holder — while 41 added to existing stakes and 29 trimmed.

The largest buyer was William Blair & Company, adding an estimated $19.6M. The largest seller was OrbiMed, exiting entirely with an estimated $35M sold.

  • 122 institutional investors held Dynavax Technologies (DVAX) as of Q3 2016, up from 121 in Q2 2016.
  • Funds reported $331M of Dynavax Technologies stock for Q3 2016, down 30% quarter-over-quarter.
  • 25 funds opened new Dynavax Technologies positions in Q3 2016 and 24 closed out, a net change of +1 holder.
  • The largest Dynavax Technologies buyer in Q3 2016 was William Blair & Company, an estimated $19.6M added.
  • The largest Dynavax Technologies seller in Q3 2016 was OrbiMed, an estimated $35M sold.

Based on aggregated 13F filings for Q3 2016.